<?xml version="1.0" encoding="UTF-8"?>
<p id="Par8">The Scopus and MEDLINE/PubMed databases were searched (from November 1st, 2019 to May 11th, 2020) by entering the following keywords; “coronavirus disease 2019”, “COVID-19”, “SARS-CoV-2”, “rheumatology”, and “rheumatic disease” according to the published guidance on narrative reviews [
 <xref ref-type="bibr" rid="CR26">26</xref>]. The complete list of the search terms used for determining articles, including COVID-19 patients with rheumatic diseases, has been provided in the Supplementary Table 1. Case reports, original research articles, editorials, and review articles with a focus on COVID-19 were analyzed. The following parameters were noted from the studies including COVID-19 patients with an underlying rheumatic disease: age, sex, underlying rheumatic disease, age at diagnosis of the rheumatic disease, features associated with rheumatic disease, other comorbidities, the previous and current treatment of rheumatic disease, COVID-19-related symptoms, the method for COVID-19 diagnosis, COVID-19 treatment and outcome, and features regarding cessation and re-initiation of immunosuppressive therapies. The search was restricted to English articles.
</p>
